Literature DB >> 16103774

Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco.

Kate Buchacz1, Willi McFarland, Timothy A Kellogg, Lisa Loeb, Scott D Holmberg, James Dilley, Jeffrey D Klausner.   

Abstract

We examined the association between amphetamine use and HIV incidence for 2991 men who have sex with men (MSM) who tested anonymously for HIV in San Francisco. HIV incidence among 290 amphetamine users was 6.3% per year (95% CI 1.9-10.6%), compared with 2.1% per year (95% CI 1.3-2.9%) among 2701 non-users (RR 3.0, 95% CI 1.4-6.5). HIV prevention programmes in San Francisco should include efforts to reduce amphetamine use and associated high-risk sexual behaviors.

Entities:  

Mesh:

Year:  2005        PMID: 16103774     DOI: 10.1097/01.aids.0000180794.27896.fb

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  80 in total

1.  Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men.

Authors:  Cathy J Reback; Steven Shoptaw
Journal:  Addict Behav       Date:  2011-11-26       Impact factor: 3.913

2.  Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies.

Authors:  Brandon D L Marshall; Evan Wood; Jean A Shoveller; Jane A Buxton; Julio S G Montaner; Thomas Kerr
Journal:  Prev Sci       Date:  2011-06

Review 3.  A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine.

Authors:  Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty
Journal:  AIDS Patient Care STDS       Date:  2011-11-09       Impact factor: 5.078

4.  Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIV.

Authors:  Stefan D Baral; Sosthenes Ketende; Sheree Schwartz; Ifeanyi Orazulike; Kelechi Ugoh; Sheila A Peel; Julie Ake; William Blattner; Manhattan Charurat
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

Review 5.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

6.  The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.

Authors:  Michael W Plankey; David G Ostrow; Ron Stall; Christopher Cox; Xiuhong Li; James A Peck; Lisa P Jacobson
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

7.  A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine.

Authors:  Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2012-10-03       Impact factor: 5.078

8.  Post-exposure prophylaxis use and recurrent exposure to HIV among men who have sex with men who use crystal methamphetamine.

Authors:  Catherine E Oldenburg; Sachin Jain; Kenneth H Mayer; Matthew J Mimiaga
Journal:  Drug Alcohol Depend       Date:  2014-11-26       Impact factor: 4.492

9.  Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia.

Authors:  Ronnye Rutledge; Olga Morozova; Britton A Gibson; Frederick L Altice; Adeeba Kamarulzaman; Jeffrey A Wickersham
Journal:  LGBT Health       Date:  2018-11-27       Impact factor: 4.151

10.  Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men.

Authors:  Perry N Halkitis; Preetika Pandey Mukherjee; Joseph J Palamar
Journal:  AIDS Behav       Date:  2008-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.